leisure time -WSS

leisure time

author：Wikipedia 2025-09-10 08:20:55 - browse：1617

What do CEOs owe the world? Did Humira break the system? And can you CRISPR a fetus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT’s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week. Then, we dive into the fascinating world of fetal genome surgery, as STAT’s Megan Molteni joins us to explain the work of a scientist named Tippi MacKenzie.

For more on what we cover, here’s the news on Gonzalez; here’s the story on MacKenzie; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Wegovy improves function in certain heart failure patients

leisure time

WSS

NIH study of ME/CFS points to clear biological hallmarks

Antivenom research: Lessons from HIV applied in search for universal antidote

Hospital at home shows how to bring innovation to health care

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

With competition flaring, obesity drug hits goal in liver disease study

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

leisure time

leisure time

entertainment

At least 13 dead in Texas as scorching temps continue

How the drug

Trump demands the U.S. pay no more for drugs than other countries … again

Listen: Vivek Ramaswamy's star turn & leaky drug data

The cancer drug shortage isn’t new — and neither are the solutions

6 phony surgeries that take placebo to the extreme

Dobbs anniversary: the lost opportunity of abortion as health care

Ed Silverman on new gene therapies, biosimilars, coffee, and more

The high cost of giving birth even with insurance

New documents shed light on MD Anderson Cancer Institute feud

leisure time

With competition flaring, obesity drug hits goal in liver disease study

Study: Spinal cord stimulation helps patients with paralysis walk again

How to make over

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

He's a Nobel laureate. Critics say he was misleading on Covid

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

leisure time

hotspot

leisure time

explore